Disulfiram Implantation for the Treatment of Alcoholism: Clinical Experiences from the Plastic Surgeon's Point of View

Background Disulfiram implantation is a widely used treatment alternative for alcohol abuse, yet reports on the surgical aspect of disulfiram implantation with respect to patient and drug-related treatment efficacy and wound complications are very limited. We present our clinical experiences with disulfiram implantation and discuss the surgical outcomes obtained with different anatomical planes for implantation.

Methods Medical records of all patients referred to our clinic from the psychiatry department between 2007 and 2013 for disulfiram implantation were retrospectively analyzed. Implantation was carried out using 10 sterile Disulfiram tablets (WZF Polfa S.A.), each tablet containing 100 mg of disulfiram. The procedure was carried out by implanting the tablets randomly in either a subcutaneous or an intramuscular plane. The location and the plane of implantation and the complications were recorded for each patient and compared to determine the differences in the outcomes.

Results A total of 32 implantation procedures were evaluated for this study. Twenty-five implants were placed in the intramuscular plane (78.2%), while seven implants were placed subcutaneously (21.8%). Exposure was encountered in three of the seven subcutaneous implants (42.9%), while no exposure was seen with the intramuscular implants. Incomplete absorption of the tablets was encountered in one patient with a previous subcutaneous implant who presented 1 year later for re-implantation as part of the continuation of therapy.

Conclusions To overcome the issue of treatment continuation in the case of disulfiram therapy, which may be ceased due to frequently encountered wound complications, we believe that implantation in the subscapular intramuscular plane allows both uneventful healing and an out-of-reach implant location.

Keywords

Alcoholism - Bioabsorbable implant - Disulfiram

This study was presented at the 35th Congress of the Turkish Society of Plastic, Reconstructive and Aesthetic Surgeons on October 28-31, 2013, in Istanbul, Turkey.

Publikationsverlauf

Eingereicht: 27. Mai 2014

Angenommen: 12. Juli 2014

Artikel online veröffentlicht:
05. Mai 2022

• References

• 1 Williams EE. Effects of alcohol on workers with carbon disulfide. JAMA 1937; 109: 1472-1473
• 2 Hald J, Jacobsen E. A drug sensitizing the organism to ethyl alcohol. Lancet 1948; 2: 1001-1004
• 3 Martensen-Larsen O. Treatment of alcoholism with a sensitizing drug. Lancet 1948; 2: 1004
• 4 Johansson B. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr Scand Suppl 1992; 369: 15-26
• 5 Allen JP, Litten RZ. Techniques to enhance compliance with disulfiram. Alcohol Clin Exp Res 1992; 16: 1035-1041
• 6 Kellam AM, Wesolkowski JM. Disulfiram implantation for alcoholism. Lancet 1968; 1: 925-926
• 7 Wilson A, Davidson WJ, White J. Disulfiram implantation: placebo, psychological deterrent, and pharmacological deterrent effects. Br J Psychiatry 1976; 129: 277-280
• 8 Johnsen J, Morland J. Disulfiram implant: a double-blind placebo controlled follow-up on treatment outcome. Alcohol Clin Exp Res 1991; 15: 532-536
• 9 Johnsen J, Stowell A, Bache-Wiig JE. et al. A double-blind placebo controlled study of male alcoholics given a subcutaneous disulfiram implantation. Br J Addict 1987; 82: 607-613
• 10 Malcolm MT, Madden JS. The use of disulfiram implantation in alcoholism. Br J Psychiatry 1973; 123: 41-45
• 11 Beasley A, Schutt-Aine A. Contraceptive procedures. Obstet Gynecol Clin North Am 2013; 40: 697-729
• 12 Cavender RK, Fairall M. Subcutaneous testosterone pellet implant (Testopel) therapy for men with testosterone deficiency syndrome: a single-site retrospective safety analysis. J Sex Med 2009; 6: 3177-3192